Alucent Biomedical Revenue and Competitors
Estimated Revenue & Valuation
- Alucent Biomedical's estimated annual revenue is currently $3M per year.
- Alucent Biomedical's estimated revenue per employee is $125,500
- Alucent Biomedical's total funding is $35.4M.
Employee Data
- Alucent Biomedical has 24 Employees.
- Alucent Biomedical grew their employee count by 4% last year.
Alucent Biomedical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP - Finance & Administration | Reveal Email/Phone |
2 | VP, Clinical Affairs | Reveal Email/Phone |
3 | VP, Head Biology | Reveal Email/Phone |
4 | VP Regulatory Affairs | Reveal Email/Phone |
5 | VP Research & Development | Reveal Email/Phone |
6 | Sr. Director Quality and Regulatory Affairs | Reveal Email/Phone |
7 | Project Manager, R&D | Reveal Email/Phone |
8 | Operations Manager | Reveal Email/Phone |
9 | Project Manager, Clinical Affairs | Reveal Email/Phone |
10 | President & CEO | Reveal Email/Phone |
Alucent Biomedical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $77.6M | 309 | 28% | N/A | N/A |
#2 | $13.8M | 55 | -17% | N/A | N/A |
#3 | $397.8M | 1585 | 7% | N/A | N/A |
#4 | $35.9M | 143 | 15% | N/A | N/A |
#5 | $75M | 157 | 43% | $12.8M | N/A |
#6 | $6.5M | 26 | 0% | N/A | N/A |
#7 | $9.3M | 37 | 9% | N/A | N/A |
#8 | $37.4M | 149 | -1% | N/A | N/A |
#9 | $143.1M | 570 | 9% | N/A | N/A |
#10 | $10.3M | 41 | -15% | N/A | N/A |
What Is Alucent Biomedical?
Alucent Medical, Inc. is a privately-held biotechnology company, based in Salt Lake City, UT, developing a novel drug-device combination therapy, Natural Vascular Scaffolding (NVS) for patients with peripheral vascular disease.
keywords:N/A
$35.4M
Total Funding
24
Number of Employees
$3M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alucent Biomedical News
2022-04-13 - Alucent Biomedical Announces First Patient Enrolled in First In ...
Alucent Biomedical is a privately held company dedicated to developing and commercializing its breakthrough Natural Vascular Scaffolding (...
2022-04-13 - Alucent Biomedical anounces first patient enrolled in first-in ...
Alucent Biomedical anounces first patient enrolled in first-in-human natural vascular scaffolding clinical trial. 12th April 2022. 3. natural...
Other Companies in Salt Lake City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 24 | 0% | N/A |
#2 | $3.7M | 24 | 9% | N/A |
#3 | $6M | 24 | 0% | N/A |
#4 | $4.9M | 24 | 4% | N/A |
#5 | $1.7M | 24 | 50% | N/A |